These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 6033503

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Central venous pressure in control of cardiogenic shock].
    Gavrilescu S, Cotoi S, Riviş I.
    Med Interna (Bucur); 1968 Nov; 20(11):1361-8. PubMed ID: 5731992
    [No Abstract] [Full Text] [Related]

  • 23. Indications for adrenergic stimulators in shock.
    Mills LC, Moyer JH.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Jun; 4(4):385-95. PubMed ID: 5566718
    [No Abstract] [Full Text] [Related]

  • 24. [Cliniccal aspects, pathogenesis and therapy of shock due to sepsis caused by gram-negative organisms].
    Meyer W.
    Schweiz Med Wochenschr; 1966 Feb 05; 96(5):137-43. PubMed ID: 4861054
    [No Abstract] [Full Text] [Related]

  • 25. [Clinical aspects, pathogenesis and therapy of shock due to sepsis caused by gram-negative organisms].
    Meyer W.
    Schweiz Med Wochenschr; 1966 Feb 05; 96(5):137-43. PubMed ID: 4862837
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Use of isoproterenol and phenoxybenzamine in treatment of endotoxin shock.
    Vick JA, Ciuchta HP, Manthei JH.
    J Pharmacol Exp Ther; 1965 Dec 05; 150(3):382-8. PubMed ID: 5852873
    [No Abstract] [Full Text] [Related]

  • 29. Current status of the treatment of shock complicating acute myocardial infarction.
    Friedberg CK.
    J Trauma; 1969 Feb 05; 9(2):141-2. PubMed ID: 5763330
    [No Abstract] [Full Text] [Related]

  • 30. Hemorrhagic and endotoxic shock: a pathophysiologic approach to diagnosis and management.
    Roberts JM, Laros RK.
    Am J Obstet Gynecol; 1971 Aug 15; 110(8):1041-9. PubMed ID: 4935087
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Glucocorticoids in prophylaxis and therapy of different kinds of shock].
    Beickert A.
    Dtsch Gesundheitsw; 1970 Oct 29; 25(44):2061-7. PubMed ID: 4923491
    [No Abstract] [Full Text] [Related]

  • 35. Use of drugs in cardiogenic shock due to acute myocardial infarction.
    Gunnar RM, Loeb HS.
    Circulation; 1972 May 29; 45(5):1111-24. PubMed ID: 4553612
    [No Abstract] [Full Text] [Related]

  • 36. Investigations on the effect of certain agents stimulating or blocking alpha and beta adrenergic receptors on the course of histamine shock in animals.
    Mazurowa A, Bocian J, Musial W.
    Pol Med J; 1969 May 29; 8(2):426-32. PubMed ID: 5772803
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. The role of vasoactive agents in shock therapy.
    Ogburn P.
    Vet Clin North Am; 1976 May 29; 6(2):287-95. PubMed ID: 775751
    [Abstract] [Full Text] [Related]

  • 40. [Microcirculatory disorders in shock].
    Zimin IuV.
    Kardiologiia; 1969 Jul 29; 9(7):121-9. PubMed ID: 4906443
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.